commercialization

Addressing challenges in using MSCs in cell therapies 3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
The development of human acellular vessels and its advantages 3:09
The development of human acellular vessels and its advantages
Alan Kypson • 22 Mar 2022
Tangential Flow Depth Filtration in viral vector manufacturing 3:03
Tangential Flow Depth Filtration in viral vector manufacturing
Rachel Legmann • 27 Jan 2022
The importance of collaboration in cell and gene therapy development 2:27
The importance of collaboration in cell and gene therapy development
Delara Motlagh • 27 Jan 2022
Improving the scalability of advanced therapies 2:27
Improving the scalability of advanced therapies
Delara Motlagh • 27 Jan 2022
Collaborating with hospitals and industry in cell therapies 1:16
Collaborating with hospitals and industry in cell therapies
Cate Dyer • 27 Jan 2022
Meeting the increasing demand for viral vectors 3:19
Meeting the increasing demand for viral vectors
Rachel Legmann • 27 Jan 2022
Strategies for large scale viral vector development 1:41
Strategies for large scale viral vector development
Rachel Legmann • 27 Jan 2022
Key developments in the future of advanced therapies 1:44
Key developments in the future of advanced therapies
Lavakumar Karyampudi • 27 Jan 2022
Achieving operational excellence in CGT through automation 4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow • 26 Jan 2022
CMC challenges in cell and gene therapy manufacturing 1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
Challenges in decentralized manufacturing systems 5:12
Challenges in decentralized manufacturing systems
Greg Roumeliotis • 26 Jan 2022
Challenges in manufacturing advanced therapies for researchers 2:25
Challenges in manufacturing advanced therapies for researchers
Kurt Gielen • 17 Nov 2021
Ensuring successful commercialization of advanced therapies 3:37
Ensuring successful commercialization of advanced therapies
Kurt Gielen • 17 Nov 2021
Overcoming hurdles associated with commercializing advanced therapies 3:32
Overcoming hurdles associated with commercializing advanced therapies
Laura Niklason • 23 Nov 2021
Developmental barriers to tissue engineered corneas 1:41
Developmental barriers to tissue engineered corneas
Mark Daniell • 8 Nov 2021
The content of VJRegenMed is intended for healthcare professionals